Business

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour.

articleMedical Marijuana, Inc.October 3, 20193/company/medical-marijuana-i/news/medical-marijuana-inc-subsidiary-kannawayr-announces-european-road-to-area-tour
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour

About this update from Medical Marijuana, Inc.

[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour\nPR Newswire\nSAN DIEGO, Oct. 3, 2019\n\n\n\nSAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (\"the Company\") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® is hosting a Road to Area Tour throughout Europe between Oct. 5-13.\n\"We're very optimistic about the future of the European CBD market as it was recently reported by the Brightfield Group that this market could be worth $419 million by the end of 2019 and upwards of $1.7 billion by 2023,\" said Kannaway® CEO Blake Schroeder. \"We've seen significant growth in our global business from our European operations and we're excited to launch in Asian markets later this month.\"\nThe Road to Area Tour, taking place in five major European cities including Paris, France (Oct. 5); Stockholm, Sweden (Oct. 6); Bratislava, Slovakia (Oct. 12); Salzburg, Austria (Oct. 13); and Milton Keynes, United Kingdom (Oct. 13) is designed to help current Kannaway® Brand Ambassadors who have achieved the Senior Director rank improve their business and become more educated regarding the therapeutic benefits of hemp-derived cannabidiol (CBD).\nThe event is structured to help Brand Ambassadors become immersed in tried-and-tested business-building methods, best practices and lessons learned from top performers and coaching from Kannaway®'s professional training team. Brand Ambassadors can also meet with and learn from Kannaway® executives such as Vice President of Kannaway® International Alex Grapov, Managing Director of Kannaway® Europe Janne Heimonen, Kannaway® Western Europe Director Ali Boukhatem, and Randy Schroeder, who is a Crown Ambassador Elite, the highest-ranking ...

More updates from Medical Marijuana, Inc.